The legal path for compounded tirzepatide narrowed to a sliver, available only for patients with verifiable clinical needs that the commercially available formulation could not meet
doi:10.1016/s1875-5364(14)60115-1 Yi LT, Li J, Geng D, et al
Am J Med Genet C 142C:7785 Szabo K, Nagy Z, Juhasz V, Zolnerciks JK, Csorba A, Timar Z, Molnar E, Padar P, Johnson W, Beery E, Krajcsi P (2016) Species specificity profiling of rat and human organic cation/carnitine transporter Slc22a5/SLC22A5 (Octn2/OCTN2)
For additional details and discussion regarding pharmacologic approaches to glycemic management, please refer to the full 2020 ADA Standards of Medical Care
What would be the best product or combination of products to use